China Injectable Drug Delivery Devices Market Growth, Size, Share, Demand and Opportunities 2032

China Injectable Drug Delivery Devices Market Size- By Type of Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery- Regional Outlook, Competitive Strategies and Segment Forecast to 2032

China Injectable Drug Delivery Devices Market Size- By Type of Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery- Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Published: Feb 2023 Report ID: MEDE2306 Pages: 1 - 103 Formats*:     
Category : Medical Devices
China Injectable Drug Delivery Devices Market Overview

According to SPER Market Research, the China Injectable Drug Delivery Devices Market is estimated to reach USD 235.46 billion by 2032 with a CAGR of 18.23%. 

The delivery and transportation of therapeutic medicine to a patient's body is accomplished using injectable devices. The equipment used to deliver injectable drugs comes in a wide variety, including traditional syringes, needle-free injectors, auto-injectors, and pen injectors. Devices for subcutaneous drug delivery are used to treat a variety of chronic and infectious disorders. In this, the medicinal medications are injected using a syringe into the layer between muscles and tissues. Compared to direct injection into veins, absorption happens more slowly.
The market for injectable drug delivery devices is predicted to grow more rapidly in the near future. It is due to the increase in public awareness and significant financial investments in medical infrastructure.
China Injectable Drug Delivery Devices Market
Impact of COVID-19 on the China Injectable Drug Delivery Devices Market  
Covid-19 is a highly contagious illness that mostly affects people's respiratory systems. The covid19 is affecting people all throughout the world. With the exception of the pharmaceutical industry, it has had a negative impact on the operation of every industry. There is an increased need for ventilators, testing supplies, medications, vaccines, and oxygen cylinders compared to before the global pandemic. The demand for injectable devices and other healthcare products increased last year, which led to a boom in the market for injectable medication delivery devices. Every country's government devotes a significant portion of its financial resources to acquiring and producing additional pharmaceuticals and medical supplies. People are becoming immunized all throughout the world. The market for injectable medicine delivery methods is growing as a result.

China Injectable Drug Delivery Devices Market


Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2032
 Base year considered 2021
 Forecast period 2022-2032
 Segments coveredBy Type of Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery
 Regions coveredNorth China, Northeast China, East China, South China, Central China, Southwest China, Northwest China.
 Companies CoveredBaxter, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, GSK plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd.
China Injectable Drug Delivery Devices Market Segmentation:
1. By Type of Devices:
  • Conventional Injection Devices
  • Self-Injection Devices
2. By Therapeutic Application:
  • Autoimmune Diseases 
  • Hormonal Disorders
  • Cancer
3. By Usage Pattern:
  • Curative pattern
  • Immunization
4. By Site of Delivery:
  • Intramuscular
  • Subcutaneous
  • Intra Dermal
5. By Region:
  • North China
  • Northeast China
  • East China
  • South China 
  • Central China
  • Southwest China
  • Northwest China
Key Topics Covered in the Report:
  • Size of China Injectable Drug Delivery Devices Market (FY’2019-FY’2032)
  • Overview of China Injectable Drug Delivery Devices Market 
  • Segmentation of China Injectable Drug Delivery Devices By Type of Devices (Conventional Injection Devices, Self-Injection Devices)
  • Segmentation of China Injectable Drug Delivery Devices Market By Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Cancer)
  • Segmentation of China Injectable Drug Delivery Devices Market By Usage Pattern (Curative pattern, Immunization)
  • Segmentation of China Injectable Drug Delivery Devices By Site of Delivery (Intramuscular, Subcutaneous, Intra Dermal)
  • Statistical Snap of China Injectable Drug Delivery Devices Market 
  • Growth Analysis of China Injectable Drug Delivery Devices Market 
  • Problems and Challenges in China Injectable Drug Delivery Devices Market 
  • Competitive Landscape in the China Injectable Drug Delivery Devices Market 
  • Impact of COVID-19 and Demonetization on China Injectable Drug Delivery Devices Market 
  • Details on Recent Investment in China Injectable Drug Delivery Devices Market 
  • Competitive Analysis of China Injectable Drug Delivery Devices Market 
  • Major Players in the China Injectable Drug Delivery Devices Market 
  • SWOT Analysis of China Injectable Drug Delivery Devices Market 
  • China Injectable Drug Delivery Devices Market Future Outlook and Projections (FY’2019-FY’2032)
  • Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation

3. Executive Summary

4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges 
4.2. COVID-19 Impacts of the China Injectable Drug Delivery Devices Market 

5. Market variables and outlook
5.1. SWOT analysis 
5.1.1 Strengths 
5.1.2 Weaknesses 
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis 
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape 
5.2.4 Technological landscape 
5.2.5 Environmental landscape 
5.2.6 Legal landscape 
5.3. PORTER’S five forces analysis 
5.3.1 Bargaining power of suppliers 
5.3.2 Bargaining power of Buyers 
5.3.3 Threat of Substitute 
5.3.4 Threat of new entrant 
5.3.5 Competitive rivalry
5.4. Heat map analysis

6. Competitive Landscape 
6.1 China Injectable Drug Delivery Devices Manufacturing Base Distribution, Sales Area, Product Type 
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in China Injectable Drug Delivery Devices Market 

7. China Injectable Drug Delivery Devices Market, By Type of Devices, 2019-2032 (USD Million)
7.1. Conventional Injection Devices
7.2. Self-Injection Devices

8. China Injectable Drug Delivery Devices Market, By Therapeutic Application, 2019-2032 (USD Million)
8.1. Autoimmune Diseases 
8.2. Hormonal Disorders
8.3. Cancer

9. China Injectable Drug Delivery Devices Market, By Usage Pattern, 2019-2032 (USD Million)
9.1. Curative pattern
9.2. Immunization

10. China Injectable Drug Delivery Devices Market, By Site of Delivery, 2019-2032 (USD Million)
10.1. Intramuscular
10.2. Subcutaneous
10.3. Intra Dermal

11. China Injectable Drug Delivery Devices Market, By Region, 2019-2032 (USD Million)
11.1. China Injectable Drug Delivery Devices Market Size and Market Share by Region (2019-2025) 
11.2. China Injectable Drug Delivery Devices Market Size and Market Share by Region (2026-2032)
11.3. North China
11.4. Northeast China
11.5. East China
11.6. South China 
11.7. Central China
11.8. Southwest China
11.9. Northwest China

12. Company Profiles
12.1. Baxter
12.1.1. Company details 
12.1.2. Financial outlook
12.1.3. Product summary 
12.1.4. Recent developments
12.2. Becton
12.2.1. Company details 
12.2.2. Financial outlook
12.2.3. Product summary 
12.2.4. Recent developments
12.3. Dickinson and Company
12.3.1. Company details 
12.3.2. Financial outlook
12.3.3. Product summary 
12.3.4. Recent developments
12.4. F. Hoffmann-La Roche AG
12.4.1. Company details 
12.4.2. Financial outlook
12.4.3. Product summary 
12.4.4. Recent developments
12.5. Gerresheimer AG
12.5.1. Company details 
12.5.2. Financial outlook
12.5.3. Product summary 
12.5.4. Recent developments
12.6. GSK plc
12.6.1. Company details 
12.6.2. Financial outlook
12.6.3. Product summary 
12.6.4. Recent developments
12.7. Merck & Co. Inc.
12.7.1. Company details 
12.7.2. Financial outlook
12.7.3. Product summary 
12.7.4. Recent developments
12.8. Novartis AG
12.8.1. Company details 
12.8.2. Financial outlook
12.8.3. Product summary 
12.8.4. Recent developments
12.9. Pfizer Inc.
12.9.1. Company details 
12.9.2. Financial outlook
12.9.3. Product summary 
12.9.4. Recent developments
12.10. Sanofi
12.10.1. Company details 
12.10.2. Financial outlook
12.10.3. Product summary 
12.10.4. Recent developments
12.11. Teva Pharmaceutical Industries Ltd
12.11.1. Company details 
12.11.2. Financial outlook
12.11.3. Product summary 
12.11.4. Recent developments

13. List of Abbreviations

14. Reference Links

15. Conclusion

16. Research Scope

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3


Frequently Asked Questions About This Report
China Injectable Drug Delivery Devices Market is projected to reach USD 235.46 billion by 2032, growing at a CAGR of 18.23% during the forecast period.
China Injectable Drug Delivery Devices Market grew in market size from 2021. The Market is expected to reach USD 235.46 billion by 2032, at a CAGR of 18.23% during the forecast period.
China Injectable Drug Delivery Devices Market CAGR of 18.23% during the forecast period.
China Injectable Drug Delivery Devices Market size is USD 235.46 billion from 2022 to 2032.
China Injectable Drug Delivery Devices Market Segment is Covered By Type of Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery.
The Asia-Pacific region is anticipated to have the highest market share in the China Injectable Drug Delivery Devices Market.
The key players in the market include Companies Covered Baxter, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, GSK plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd.
The market for injectable drug delivery devices is predicted to grow more rapidly in the near future. It is due to the increase in public awareness and significant financial investments in medical infrastructure.
Not able to find what you are looking for? Need customization in the existing report?
Click Here

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-SIEMENS
SPER-IQVIA
SPER-Pfizer
SPER-LOREAL
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-IPSOS
SPER-Heineken

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]

 +91-742-898-5650